Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 4/20 | 0.48 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.48 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | TACR1 | P25103 | 1/20 | 0.44 |
| ▸ | F10 | P00742 | 2/20 | 0.44 |
| ▸ | SPTLC2 | O15270 | 5/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5735667 | 1.00 | GRM5 (0.48) | GRM5TAS1R3TAS1R1L3MBTL1NPC1 | |
| SCHEMBL5734102 | 0.91 | TAS1R3 (0.53) | TAS1R3TAS1R1TACR1F10SPTLC2 | |
| SCHEMBL5734110 | 0.91 | TAS1R3 (0.53) | TAS1R3TAS1R1TACR1F10SPTLC2 | |
| SCHEMBL5733895 | 0.90 | TACR1 (0.51) | TAS1R3TAS1R1TACR1SPTLC2 | |
| SCHEMBL5733889 | 0.90 | TACR1 (0.51) | TAS1R3TAS1R1TACR1SPTLC2 | |
| SCHEMBL5733689 | 0.89 | TACR1 (0.45) | GRM5TAS1R3TAS1R1NPC1RAB9A | |
| SCHEMBL5733686 | 0.89 | TACR1 (0.45) | GRM5TAS1R3TAS1R1NPC1RAB9A | |
| SCHEMBL5734789 | 0.88 | TACR1 (0.49) | TAS1R3TAS1R1TACR1SPTLC2 | |
| SCHEMBL5734799 | 0.88 | TACR1 (0.49) | TAS1R3TAS1R1TACR1SPTLC2 | |
| SCHEMBL5733789 | 0.86 | ALDH1A1 (0.52) | TAS1R3TAS1R1NPC1RAB9ATACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1650193-A2 | 6-Phenylphenanthridines with PDE-IV inhibiting activity | ALTANA Pharma AG (DE) | 2006-04-26 | — | — | EP | disclosed |
| EP-1147089-B1 | PHENYLPHENANTHRIDINES WITH PDE-IV INHIBITING ACTIVITY | ALTANA PHARMA AG (DE) | 2005-12-07 | — | — | EP | disclosed |
| US-6476025-B1 | Phenylphennanthridines with PDE-IV inhibiting activity | ALTANA PHARMA AG (DE) | 2002-11-05 | — | — | US | disclosed |
| EP-1147089-A1 | PHENYLPHENANTHRIDINES WITH PDE-IV INHIBITING ACTIVITY | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2001-10-24 | — | — | EP | disclosed |
| WO-2000042020-A1 | PHENYLPHENANTHRIDINES WITH PDE-IV INHIBITING ACTIVITY | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2000-07-20 | — | — | WO | disclosed |